NCT07707037 Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids
| NCT ID | NCT07707037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Cardiac Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-06-01 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot randomized controlled trial (RCT) will test the feasibility and acceptability of the informational intervention program, Heartsight, to reduce caregivers' uncertainty experienced throughout their child's illness trajectory after cardiac arrest. The investigator aims to enroll up to 30 caregivers of pediatric cardiac arrest patients to (Aim 1a) pilot recruitment and randomization (2:1) procedures, and (Aim 1b) estimate retention rate at 3 months and assess engagement and utilization metrics for frequency of access and time spent on each module of the informational packages. The investigator also aims to evaluate the association of the intervention with efficacy outcomes in an exploratory manner in preparation for a larger trial, including (Aim2a) a preliminary estimate of the association of intervention with the surrogate's uncertainty levels at 3 months post-discharge, and (Aim 2b) a preliminary estimate of the association of intervention with the surrogate's anxiety, depression, and post-traumatic stress symptoms at 3 months post-discharge.
Eligibility Criteria
Inclusion Criteria: Caregiver 1. Caregiver of a child \<17.5 years of age who had at least a 2 minute cardiac arrest, is expected to be discharged within 30 days, and to survive at least 3 months post-discharge from hospital. 2. English speaking Child 1. \<17.5 years of age 2. Have had a cardiac arrest lasting more than 2 minutes within the past 7 days and have not yet been discharged from pediatric intensive care unit (PICU) or cardiac intensive care unit (CICU) Exclusion Criteria: 1\) Parent or legal guardian is not the child's caregiver
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07707037 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 17 Years, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07707037 currently recruiting?
Yes, NCT07707037 is actively recruiting participants. Contact the research team at herrupe@chop.edu for enrollment information.
Where is the NCT07707037 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07707037 clinical trial?
NCT07707037 is sponsored by Children's Hospital of Philadelphia. The trial plans to enroll 30 participants.